摘要
目的:研究替格瑞洛联合抗栓胶囊治疗急性心肌梗死的效果.方法:选择2020年1月—2022年12月本院收治的 80 例急性心肌梗死患者,随机分为对照组和观察组,每组 40 例.对照组服用替格瑞洛,观察组联用抗栓胶囊.比较两组血液流变学指标(全血还原黏度、血栓形成系数、全血黏度、凝血因子Ⅰ和血浆黏度)、中医症状评分、血清超氧化物歧化酶(SOD)、髓过氧化物酶(MPO)、丙二醛(MDA)和可溶性致癌抑制因子 2(sST2)水平.结果:观察组全血还原黏度、血栓形成系数、全血黏度、凝血因子Ⅰ和血浆黏度低于对照组(P<0.05);观察组心悸、胸闷、眩晕、痰多气短和神疲乏力评分低于对照组(P<0.05);观察组血清MPO、MDA和sST2水平低于对照组,SOD水平高于对照组(P<0.05).结论:替格瑞洛联合抗栓胶囊对急性心肌梗死有显著的效果,能明显改善血液流变学,减轻症状,有效改善氧化应激状态.
Abstract
Objective:To study the effect of ticagrelor combined with antithrombotic capsule in the treatment of acute myocardial infarction.Methods:A total of 80 patients with acute myocardial infarction admitted to our hospital from January 2020 to December 2022 were randomly divided into control group and observation group,with 40 patients in each group.The control group was treated with ticagrelor,and the observation group was treated with antithrombotic capsules.The hemorheological indexes(whole blood reduced viscosity,thrombosis coefficient,whole blood viscosity,coagulation factor Ⅰ and plasma viscosity),TCM symptom score,serum superoxide dismutase(SOD),myeloperoxidase(MPO),malondialdehyde(MDA)and soluble carcinogenic inhibitor 2(sST2)levels were compared between the two groups.Results:The whole blood reduced viscosity,thrombosis coefficient,whole blood viscosity,coagulation factor Ⅰ and plasma viscosity in the observation group were lower than those in the control group(P<0.05).The scores of palpitation,chest tightness,vertigo,phlegm and shortness of breath and mental fatigue in the observation group were lower than those in the control group(P<0.05).The levels of serum MPO,MDA and sST2 in the observation group were lower than those in the control group,and the level of SOD was higher than that in the control group(P<0.05).Conclusion:Ticagrelor combined with antithrombotic capsule has a significant effect on acute myocardial infarction,which can significantly improve hemorheology,relieve symptoms and effectively improve oxidative stress.
NETL
NSTL
万方数据